ACLX
Price
$76.19
Change
-$1.49 (-1.92%)
Updated
Sep 12 closing price
Capitalization
4.23B
65 days until earnings call
LGND
Price
$165.75
Change
-$1.31 (-0.78%)
Updated
Sep 12 closing price
Capitalization
3.23B
53 days until earnings call
Interact to see
Advertisement

ACLX vs LGND

Header iconACLX vs LGND Comparison
Open Charts ACLX vs LGNDBanner chart's image
Arcellx
Price$76.19
Change-$1.49 (-1.92%)
Volume$785.52K
Capitalization4.23B
Ligand Pharmaceuticals
Price$165.75
Change-$1.31 (-0.78%)
Volume$298.64K
Capitalization3.23B
ACLX vs LGND Comparison Chart in %
Loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LGND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACLX vs. LGND commentary
Sep 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACLX is a StrongBuy and LGND is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 13, 2025
Stock price -- (ACLX: $76.19 vs. LGND: $165.75)
Brand notoriety: ACLX and LGND are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACLX: 151% vs. LGND: 125%
Market capitalization -- ACLX: $4.23B vs. LGND: $3.23B
ACLX [@Biotechnology] is valued at $4.23B. LGND’s [@Biotechnology] market capitalization is $3.23B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.15B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACLX’s FA Score shows that 0 FA rating(s) are green whileLGND’s FA Score has 0 green FA rating(s).

  • ACLX’s FA Score: 0 green, 5 red.
  • LGND’s FA Score: 0 green, 5 red.
According to our system of comparison, LGND is a better buy in the long-term than ACLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACLX’s TA Score shows that 6 TA indicator(s) are bullish while LGND’s TA Score has 2 bullish TA indicator(s).

  • ACLX’s TA Score: 6 bullish, 4 bearish.
  • LGND’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, ACLX is a better buy in the short-term than LGND.

Price Growth

ACLX (@Biotechnology) experienced а +4.92% price change this week, while LGND (@Biotechnology) price change was -0.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.38%. For the same industry, the average monthly price growth was +7.84%, and the average quarterly price growth was +35.14%.

Reported Earning Dates

ACLX is expected to report earnings on Nov 17, 2025.

LGND is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+1.38% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACLX($4.23B) has a higher market cap than LGND($3.23B). LGND YTD gains are higher at: 54.690 vs. ACLX (-0.652). LGND has higher annual earnings (EBITDA): -45.94M vs. ACLX (-179.78M). ACLX has more cash in the bank: 453M vs. LGND (255M). LGND has less debt than ACLX: LGND (5.74M) vs ACLX (52.5M). LGND has higher revenues than ACLX: LGND (188M) vs ACLX (57M).
ACLXLGNDACLX / LGND
Capitalization4.23B3.23B131%
EBITDA-179.78M-45.94M391%
Gain YTD-0.65254.690-1%
P/E RatioN/A46.19-
Revenue57M188M30%
Total Cash453M255M178%
Total Debt52.5M5.74M914%
FUNDAMENTALS RATINGS
LGND: Fundamental Ratings
LGND
OUTLOOK RATING
1..100
75
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
43
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
50
P/E GROWTH RATING
1..100
91
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACLXLGND
RSI
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
59%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
76%
Bearish Trend 1 day ago
70%
Momentum
ODDS (%)
Bullish Trend 1 day ago
90%
N/A
MACD
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
89%
Bearish Trend 1 day ago
73%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
75%
Advances
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
75%
Declines
ODDS (%)
Bearish Trend 20 days ago
78%
Bearish Trend 5 days ago
73%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 1 day ago
77%
Aroon
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LGND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HNCCX18.52N/A
N/A
Hartford International Growth C
PMBCX37.89N/A
N/A
Principal MidCap C
GGOUX23.83N/A
N/A
Goldman Sachs Mid Cap Growth R6
PSCJX24.51N/A
N/A
PGIM Jennison Small Company R4
JVSNX16.54N/A
N/A
Janus Henderson Small-Mid Cap Value N

ACLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACLX has been loosely correlated with CGON. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ACLX jumps, then CGON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACLX
1D Price
Change %
ACLX100%
-1.92%
CGON - ACLX
56%
Loosely correlated
+0.54%
ROIV - ACLX
54%
Loosely correlated
-2.29%
XNCR - ACLX
53%
Loosely correlated
+1.18%
RNA - ACLX
52%
Loosely correlated
+9.02%
CRNX - ACLX
52%
Loosely correlated
+0.80%
More

LGND and

Correlation & Price change

A.I.dvisor indicates that over the last year, LGND has been loosely correlated with AGIO. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if LGND jumps, then AGIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LGND
1D Price
Change %
LGND100%
-0.78%
AGIO - LGND
50%
Loosely correlated
+0.77%
AXON - LGND
49%
Loosely correlated
+0.67%
CRSP - LGND
48%
Loosely correlated
+0.66%
SYRE - LGND
48%
Loosely correlated
-3.40%
ACLX - LGND
45%
Loosely correlated
-1.92%
More